HRMY
Harmony Biosciences Holdings, Inc.
+0.24 (+0.57%)42.45USD198K成交股數2.5B市值13.8本益比(近四季)2.6股價營收比+30.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 261M+41% | 215M+7% | 239M+29% | 200M+16% | 185M+19% | 201M+26% | 186M+39% | 173M+45% | 155M | 160M | 134M | 119M |
| 營業成本 | 63.2M | 44.5M | 59.7M | 38.2M | 32.0M | 54.4M | 42.8M | 32.1M | 27.5M | 32.3M | 25.0M | 20.8M |
| 毛利 | 198M+30% | 171M+16% | 180M+26% | 162M+15% | 153M+20% | 147M+15% | 143M+31% | 141M+43% | 127M | 128M | 109M | 98.3M |
| 毛利率 | 75.8% | 79.3% | 75.1% | 81.0% | 82.7% | 73.0% | 77.0% | 81.4% | 82.2% | 79.8% | 81.4% | 82.6% |
| 研發費用 | 46.6M | 69.4M | 55.0M | 50.2M | 34.5M | 34.7M | 25.4M | 63.6M | 22.2M | 17.5M | 15.0M | 13.3M |
| 銷售管理費用 | 28.1M | 32.5M | 29.8M | 33.9M | 31.2M | 28.9M | 28.6M | 27.2M | 25.7M | 22.5M | 22.8M | 22.1M |
| 營業利益 | 89.3M+59% | 37.3M-33% | 65.5M+6% | 48.2M+126% | 56.2M+8% | 55.7M-14% | 61.7M+32% | 21.4M-47% | 52.0M | 64.5M | 46.9M | 40.4M |
| 營業利益率 | 34.2% | 17.3% | 27.3% | 24.0% | 30.4% | 27.7% | 33.2% | 12.4% | 33.7% | 40.3% | 34.9% | 33.9% |
| 稅後淨利 | 75.4M+66% | 32.5M-34% | 50.9M+10% | 39.8M+243% | 45.6M+19% | 49.5M+29% | 46.1M+34% | 11.6M-61% | 38.3M | 38.5M | 34.3M | 29.5M |
| 淨利率 | 28.9% | 15.1% | 21.2% | 19.8% | 24.7% | 24.6% | 24.8% | 6.7% | 24.8% | 24.0% | 25.6% | 24.8% |
| 稀釋 EPS | 1.28+64% | 0.55-35% | 0.87+10% | 0.68+240% | 0.78+16% | 0.85+35% | 0.79+41% | 0.20-58% | 0.67 | 0.63 | 0.56 | 0.48 |
| 稀釋股數 | 58.8M | 58.8M | 58.7M | 58.4M | 58.5M | 57.9M | 58.1M | 57.5M | 57.6M | 60.7M | 60.7M | 61.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 550M | 589M | 647M | 546M | 489M | 453M | 387M | 317M | 333M | 325M | 317M | 288M |
| 應收帳款 | 111M | 108M | 101M | 93.0M | 106M | 83.0M | 81.5M | 83.2M | 79.7M | 67.3M | 63.8M | 52.6M |
| 存貨 | 6.4M | 5.3M | 6.9M | 6.1M | 6.4M | 7.2M | 6.9M | 5.6M | 5.9M | 5.1M | 4.9M | 4.1M |
| 總資產 | 1.4B | 1.3B | 1.2B | 1.1B | 1.1B | 999M | 928M | 858M | 847M | 778M | 760M | 715M |
| 有息負債 | 134M | 139M | 149M | 153M | 158M | 163M | 168M | 171M | 175M | 182M | 180M | 185M |
| 總負債 | 374M | 361M | 373M | 335M | 335M | 340M | 331M | 320M | 332M | 296M | 275M | 272M |
| 股東權益 | 999M | 910M | 835M | 773M | 721M | 659M | 597M | 539M | 515M | 481M | 485M | 443M |
| 負債比 | 27.2% | 28.4% | 30.9% | 30.2% | 31.7% | 34.0% | 35.7% | 37.3% | 39.1% | 38.1% | 36.2% | 38.0% |
| 淨現金(現金 − 有息負債) | 416M | 451M | 498M | 393M | 331M | 290M | 220M | 146M | 158M | 142M | 137M | 103M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 27.8M | – | – | 34.0M+9% | – | – | – | 31.1M | – | – | 42.6M |
| 資本支出 | – | – | – | – | 128K | – | – | – | 5K | – | – | – |
| 自由現金流 | – | – | – | – | 33.9M+9% | – | – | – | 31.1M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | 18.3% | – | – | – | 20.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 868M
| Rare Neurological Diseases | 868M | 100.0% | +21.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 868M | +21.5% | 159M | 18.3% | 2.71 | 348M |
| FY2024 | 715M | +22.8% | 145M | 20.4% | 2.51 | 219M |
| FY2023 | 582M | +32.9% | 129M | 22.1% | 2.13 | 219M |
| FY2022 | 438M | +43.4% | 181M | 41.4% | 2.97 | 144M |
| FY2021 | 305M | +91.2% | 34.6M | 11.3% | 0.58 | 98.3M |
| FY2020 | 160M | +2564.6% | −36.9M | -23.1% | -2.48 | −3.0M |
| FY2019 | 6.0M | – | −152M | -2,535.1% | -24.07 | −75.6M |